Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Bliss O'bryhim (NPI 1427439298)

Field	Value
Entity Type	Individual
Organization	Bliss O'bryhim
Address	517 S Euclid Ave
City	Saint Louis
State	MO
ZIP	63110
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 17, 2015

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

BLISS O'BRYHIM is a retina specialist whose Medicare billing is dominated by high-cost intravitreal drug injections and retina imaging/procedures, consistent with a practice focused on medical retina care rather than broad ophthalmic surgery. The top revenue code is J0178 (aflibercept) generating $713.8K (47.8% of Medicare revenue), supplemented by J2777 (faricimab) with $403.7K (27.0%) and 67028 intravitreal injection with $95K (6.4%); these three codes together account for 81.2% of the provider's total Medicare revenue, indicating concentrated dependence on anti-VEGF/biologic therapies and intravitreal procedures.

This provider’s Medicare revenue totals $1.5M while there is no Medicaid billing on file, making the practice effectively single-payer in the available data. Absence of Medicaid billing suggests either limited participation in Medicaid plans, a patient panel skewed toward Medicare-age beneficiaries, or billing relationships that do not route services through state Medicaid — but the data as reported show Medicare exclusively generating the documented lifetime revenue.

The revenue concentration around J0178 and J2777 implies operational capacity and supply-chain handling for high-volume biologic injections: the provider reported 1K claims for J0178 and 13.9K claims for J2777, with J0178 accounting for nearly half of Medicare revenue and J2777 contributing more than a quarter. Such a code mix typically reflects frequent treatment of neovascular retinal diseases (e.g., wet AMD, diabetic macular edema) and an office workflow set up to deliver frequent intravitreal injections and associated imaging.

Competitive standing by national percentile is mixed: the provider ranks in the 61st percentile for J0178 and the 63rd percentile for J2777, which the data label as "typical, unremarkable volume" and indicate this clinician is a modest national participant for those high-revenue drugs rather than an outsized market leader. In contrast, imaging code 92134 is at the 95th percentile and described as "notably above typical national volume," showing exceptional relative activity in retinal computerized diagnostic imaging compared with peers.

Office evaluation and management and procedure volumes are present but secondary to injection services: codes 99213, 99212, and 99214 together generate modest shares ($36.6K, $7.4K, and $7.8K respectively) and rank at or above typical percentiles (99213 at the 96th percentile), which suggests a steady outpatient follow-up load consistent with frequent injection clinics and monitoring visits. Procedure codes for surgeries (e.g., 66984 cataract surgery, 67042 vitrectomy) appear but contribute small portions of revenue ($14.7K and $9.9K respectively), reinforcing that the primary business is medical retina rather than surgical cataract or vitrectomy volume.

Several miscellaneous and unclassified drug/biologic codes (J3490, J3590, J9035, J9035) and imaging adjuncts (92250, 92235) appear in the top list but represent small revenue shares; J3490 produced $37.7K (2.5% of Medicare revenue) and J3590 produced $19.7K (1.3%). These items indicate occasional use or billing of non-standard drug/biologic items and supplementary imaging services, but they are not materially driving the practice’s revenue profile.

The provider has been NPI enumerated since 2015-06-17 (~11 years ago), indicating an established practice tenure sufficient to have developed a stable referral and treatment pattern for retina services. Over that period the lifetime Medicare revenue reported is $1.5M, consistent with a focused specialty practice that concentrates earnings in recurring in-office treatments rather than large volumes of surgical procedures.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,040	$690	$713.8K
J2777	Injection, faricimab‑svoa, 0.1 mg	13,920	$30	$403.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,140	$80	$95K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,750	$30	$50.7K
J2778	Injection, ranibizumab, 0.1 mg	290	$180	$50.6K
J3490	Unclassified drugs	20	$1,720	$37.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	600	$60	$36.6K
J3590	Unclassified biologics	290	$70	$19.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	220	$80	$17.2K
66984	The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to…	40	$370	$14.7K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Bliss O'bryhim — 3 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	25	60	820	$690	$683.3K
J2777	20	50	11,730	$30	$388.9K
J2778	19	20	540	$180	$203.8K
66984	254	420	50	$390	$74K
67028	21	80	600	$90	$69.7K
67042	28	30	20	$1,070	$26.8K
J9035	34	40	170	$60	$21.8K
66821	214	220	50	$210	$21.2K
J3590	3	30	80	$160	$19K
92014	235	730	120	$80	$18K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Bliss O'bryhim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Physicians Clinic Inc	NE	Family Medicine Physician	$0	$20.5M
Matthew Appenzeller	NE	Ophthalmology Physician	$2.5M	$0
Mark Emig	NE	Ophthalmology Physician	$2.2M	$0
David Ingvoldstad	NE	Ophthalmology Physician	$1.8M	$0
Montgomery County Memorial Hospital	IA	Critical Access Hospital	$0	$1.7M
Edward Taylor	NE	Internal Medicine Physician	$658.9K	$0
Michael Feilmeier	NE	Ophthalmology Physician	$617.6K	$0
Patricia Terp	NE	Ophthalmology Physician	$529.1K	$0
Thomas Franco	NE	Physical Medicine & Rehabilitation Physician	$526.6K	$0
Jesse Himebaugh	NE	Ophthalmology Physician	$412.6K	$0

Nearby Providers

Other providers in the same ZIP code as Bliss O'bryhim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Council For Extended Care	MO	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$98.1M
St. Louis Children's Hospital	MO	Children's Hospital	$0	$66.9M
Barnes Jewish Hospital	MO	General Acute Care Hospital	$0	$61.4M
Paraquad Inc	MO	Customized Equipment (DME)	$0	$56.3M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$22M
Cooperative Home Care, Inc.	MO	Home Health Agency	$0	$20.6M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$14.8M
New Beginnings In Home Services, LLC	MO	In Home Supportive Care Agency	$0	$11.6M
Washington University	MO	Multi-Specialty Clinic/Center	$0	$10.4M
Washington University	MO	Emergency Care Clinic/Center	$0	$9.1M

Bliss O'bryhim — Billing Profile & Reimbursement Data

Sign up for Bliss O'bryhim — Billing Profile & Reimbursement Data policy alerts

Bliss O'bryhim — Billing Profile & Reimbursement Data

Sign up for Bliss O'bryhim — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References